Krishna Kumar Veeravalli

Dr. Krishna Kumar Veeravalli


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Stem Cells
Verified
Journal Article
Open access
VDVenkata Ramesh Dasari
Venkata Ramesh Dasari
KVKrishna Kumar Veeravalli
Krishna Kumar Veeravalli
DDDzung Dinh
Dzung Dinh
Mesenchymal stem cells in the treatment of spinal cord injuries: A review

1 November 2017 in Cell Reports
Verified
Journal Article
Open access
YNYelena Nersesyan
Yelena Nersesyan
LDLusine Demirkhanyan
Lusine Demirkhanyan
DCDeny Cabezas-Bratesco
Deny Cabezas-Bratesco
VOVictoria Oakes
Victoria Oakes
RKRicardo Kusuda
Ricardo Kusuda
EZEleonora Zakharian
Eleonora Zakharian
Oxytocin is a hormone with various actions. Oxytocin-containing parvocellular neurons project to the brainstem and spinal cord. Oxytocin release from these neurons suppresses nociception of inflammatory pain, the molecular mechanism of which remains unclear. Here, we report that the noxious stimulus receptor TRPV1 is an ionotropic oxytocin receptor. Oxytocin elicits TRPV1 activity in native and heterologous expression systems, regardless of the presence of the classical oxytocin receptor. In TRPV1 knockout mice, DRG neurons exhibit reduced oxytocin sensitivity relative to controls, and oxytocin injections significantly attenuate capsaicin-induced nociception in in vivo experiments. Furthermore, oxytocin potentiates TRPV1 in planar lipid bilayers, supporting a direct agonistic action. Molecular modeling and simulation experiments provide insight into oxytocin-TRPV1 interactions, which resemble DkTx. Together, our findings suggest the existence of endogenous regulatory pathways that modulate nociception via direct action of oxytocin on TRPV1, implying its analgesic effect via channel desensitization.

1 December 2015 in Stroke
Verified
Journal Article
Closed access
PDF file
BCBharath Chelluboina
Bharath Chelluboina
JKJeffrey D. Klopfenstein
Jeffrey D. Klopfenstein
DPDavid M. Pinson
David M. Pinson
DWDavid Z. Wang
David Z. Wang
RVRaghu Vemuganti
Raghu Vemuganti
KVKrishna Kumar Veeravalli
Krishna Kumar Veeravalli
Background and Purpose—: Matrix metalloproteinases (MMPs) have a central role in compromising the integrity of the blood–brain barrier (BBB). The role of MMP-12 in brain damage after ischemic stroke remains unknown. The main objective of the current study is to investigate the effect of MMP-12 suppression at an early time point before reperfusion on the BBB damage in rats. Methods—: Sprague–Dawley rats were subjected to middle cerebral artery occlusion and reperfusion. MMP-12 shRNA–expressing plasmids formulated as nanoparticles were administered at a dose of 1 mg/kg body weight. The involvement of MMP-12 on BBB damage was assessed by performing various techniques, including Evans blue dye extravasation, 2,3,5-triphenyltetrazolium chloride staining, immunoblot, gelatin zymography, and immunofluorescence analysis. Results—: MMP-12 is upregulated ≈31-, 47-, and 66-fold in rats subjected 1–, 2-, or 4-hour ischemia, respectively, followed by 1-day reperfusion. MMP-12 suppression protected the BBB integrity by inhibiting the degradation of tight-junction proteins. Either intravenous or intra-arterial delivery of MMP-12 shRNA-expressing plasmid significantly reduced the percent Evans blue dye extravasation and infarct size. Furthermore, MMP-12 suppression reduced the endogenous levels of other proteases, such as tissue-type plasminogen activator and MMP-9, which are also known to be the key players involved in BBB damage. Conclusions—: These results demonstrate the adverse role of MMP-12 in acute brain damage that occurs after ischemic stroke and, thereby, suggesting that MMP-12 suppression could be a promising therapeutic target for cerebral ischemia.

7 July 2011 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
RKRamaprasada Rao Kotipatruni
Ramaprasada Rao Kotipatruni
VDVenkata Ramesh Dasari
Venkata Ramesh Dasari
KVKrishna Kumar Veeravalli
Krishna Kumar Veeravalli
DDDzung H. Dinh
Dzung H. Dinh
DFDaniel Fassett
Daniel Fassett
JRJasti S. Rao
Jasti S. Rao

28 June 2013 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
BCBharath Chelluboina
Bharath Chelluboina
JKJeffrey D. Klopfenstein
Jeffrey D. Klopfenstein
MGMeena Gujrati
Meena Gujrati
JRJasti S. Rao
Jasti S. Rao
KVKrishna Kumar Veeravalli
Krishna Kumar Veeravalli
A tremendous effort has been expended to elucidate the role of apoptotic molecules in ischemia. However, many agents that target apoptosis, despite their proven efficacy in animal models, have failed to translate that efficacy and specificity in clinical settings. Therefore, comprehensive knowledge of apoptotic mechanisms involving key apoptotic regulatory molecules and the temporal expression profiles of various apoptotic molecules after cerebral ischemia may provide insight for the development of better therapeutic strategies aimed at cerebral ischemia. The present study investigates the extent of apoptosis and the regulation of apoptotic molecules both at mRNA and protein levels at various time points after focal cerebral ischemia in a rat model of middle cerebral artery occlusion. In this study, we performed various techniques, such as TTC (2,3,5-triphenyltetrazolium chloride), H&E (hematoxylin and eosin), and TUNEL (terminal deoxy nucleotidyl transferase-mediated nick-end labeling) staining, along with polymerase chain reaction (PCR) microarray, antibody microarray, reverse transcription (RT)-PCR, immunofluorescence, and immunoblot analyses. Our research provided a large list of pro-apoptotic and anti-apoptotic molecules and their temporal expression profiles both at the mRNA and protein levels. This information could be very useful for designing future stroke therapies and aid in targeting the right molecules at critical time to obtain maximum therapeutic benefit.

1 January 2005 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
PRPragada Rajeswara Rao
Pragada Rajeswara Rao
KVKrishna Kumar Veeravalli
Krishna Kumar Veeravalli
RVRouthu Kasi Viswanath
Routhu Kasi Viswanath
GSGottumukkala Venkata Subbaraju
Gottumukkala Venkata Subbaraju
It has been suggested that the beneficial effects of reperfusing the myocardium might be in part reversed by the occurrence of reperfusion injury. Oxidative stress was suggested to be implicating in the pathogenesis of ischemia-reperfusion (I/R) injury. Many antioxidative plants were shown to be cardioprotective in experimental models of myocardial ischemia-reperfusion (I/R) injury. The present study was designed to investigate the effects of pretreatment with alcoholic extract of Tinospora cordifolia in an in vivo rat model. The model adopted was that of surgically-induced myocardial ischemia, performed by means of left anterior descending coronary artery occlusion (LAD) for 30 min followed by reperfusion for another 4 h. Infarct size was measured by using the staining agent TTC (2,3,5-triphenyl tetrazolium chloride). Lipid peroxide levels in serum and in heart tissue were estimated spectrophotometrically by the methods developed by Yagi and Ohkawa et al. respectively. A lead II electrocardiogram was monitored at various intervals throughout the experiment. A dose dependent reduction in infarct size and in lipid peroxide levels of serum and heart tissue were observed with the prior treatment of T. cordifolia with various doses for 7 d compared to control animals. Hence, the present study suggests the cardioprotective activity of T. cordifolia in limiting ischemia-reperfusion induced myocardial infarction.